Publications and articles

26 May 2026

De Brauw contributes Netherlands chapters to (1) Lexology In-Depth and (2) Lexology Panoramic – Private Equity 2026

Our contribution to the 15th edition of Lexology In-Depth provides a detailed overview of the key legal and regulatory aspects of private equity transactions and fundraising in the Netherlands, with a practical focus on recent deal activity and market dynamics, sale processes, management incentive plans, financing trends, the regulatory landscape and our outlook for the year ahead. The Investing chapter was written by Lennard Keijzer, Pete Lawley, Claudia van Rappard-Priem, Rick van 't Wout, Stephanie The, Henk van Ravenhorst, Jeroen Kolthof, Bob de Waard, Lorenzo Ramnarain and various other team members. The Fundraising chapter was written by Mariska Enzerink and Lisa Brouwer. Lexology In-Depth brings together on-the-ground insight from practitioners at the forefront of private equity across key jurisdictions, offering a current and practical perspective on the issues that matter most.
21 May 2026

Dutch senate approves bonus cap relaxation in financial sector

The Dutch parliament's upper house has adopted an amendment that narrows the applicability of the bonus cap at financial institutions in the Netherlands to "identified staff". The amendment forms part of a broader bill amending the Financial Supervision Act (FSA) and related legislation. The bill is expected to enter into force on 1 January 2027.
21 May 2026

Europe’s new draft merger guidelines: an evolved framework for a competitive era

The European Commission has published its new and highly anticipated Draft Merger Guidelines, the first comprehensive restatement of EU merger assessment in almost two decades. The draft consolidates two previously separate instruments into a single analytical framework organised by competitive effect rather than merger type. Its most consequential change is the formal introduction of a theory of benefit as a central analytical concept, sitting alongside the established theory of harm from the outset of any transaction review. The Commission has also significantly broadened the analysis, with an expanded list of harms and benefits that can play a role in the overall assessment. Although the Commission is not exactly ''relaxing'' the rules to create "European champions", it is certainly widening their application and recalibrating its approach to deal reviews by offering much more room for broader policy considerations.
Phenster De Brauw7 Mrt 0076

Client Events

We put news, trends and developments in the context of our clients' needs. What do they mean to our clients and how can we help them?

Event calendar

Highlighted Topics

Client Toolboxes

Navigating Uncertainties